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Abstract
In the present study, we aim to elucidate the roles of caveolin-1(Cav-1), a 22 kDa protein in plasma membrane
invaginations, in modulating neuronal differentiation of neural progenitor cells (NPCs). In the hippocampal dentate gyrus,
we found that Cav-1 knockout mice revealed remarkably higher levels of vascular endothelial growth factor (VEGF) and the
more abundant formation of newborn neurons than wild type mice. We then studied the potential mechanisms of Cav-1 in
modulating VEGF signaling and neuronal differentiation in isolated cultured NPCs under normoxic and hypoxic conditions.
Hypoxic embryonic rat NPCs were exposed to 1% O2 for 24 h and then switched to 21% O2 for 1, 3, 7 and 14 days whereas
normoxic NPCs were continuously cultured with 21% O2. Compared with normoxic NPCs, hypoxic NPCs had down-
regulated expression of Cav-1 and up-regulated VEGF expression and p44/42MAPK phosphorylation, and enhanced
neuronal differentiation. We further studied the roles of Cav-1 in inhibiting neuronal differentiation by using Cav-1
scaffolding domain peptide and Cav-1-specific small interfering RNA. In both normoxic and hypoxic NPCs, Cav-1 peptide
markedly down-regulated the expressions of VEGF and flk1, decreased the phosphorylations of p44/42MAPK, Akt and Stat3,
and inhibited neuronal differentiation, whereas the knockdown of Cav-1 promoted the expression of VEGF,
phosphorylations of p44/42MAPK, Akt and Stat3, and stimulated neuronal differentiation. Moreover, the enhanced
phosphorylations of p44/42MAPK, Akt and Stat3, and neuronal differentiation were abolished by co-treatment of VEGF
inhibitor V1. These results provide strong evidence to prove that Cav-1 can inhibit neuronal differentiation via down-
regulations of VEGF, p44/42MAPK, Akt and Stat3 signaling pathways, and that VEGF signaling is a crucial target of Cav-1. The
hypoxia-induced down-regulation of Cav-1 contributes to enhanced neuronal differentiation in NPCs.
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Introduction
Neural progenitor or stem cells (NPCs) can potentially generate
new functional neurons for brain repair in the adult central
nervous system (CNS) [1,2]. Neurogenesis can be divided into
several stages including proliferation, maturation, differentiation
and integration, etc which mainly occur in two areas of adult
brains, that is, the subventricular zone (SVZ) lining the lateral
ventricle and the subgranular zone (SGZ) in the dentate gyrus of
hippocampus [3,4]. The division and differentiation of these
endogenous NSCs can be regulated by physiological stimuli and
pathological conditions [5]. Enhanced neurogenesis has been
reported in hypoxic NPCs in vitro [6,7] and in ischemic brains of
neonatal mice [8], adult rats [9] and aged humans in vivo [10]. For
examples, exposure to 1–5% oxygen concentration improved
NPCs proliferation, survival and dopaminergic neuron develop-
ment [11,12]. Mild hypoxia (2.5 to 5% oxygen) remarkably
promoted proliferation and differentiation of human neural stem
cells into neuro-oligodendroglial progenitors [13]. Cerebral
ischemia increased neurogenesis and promoted the normal
development of newly generated neurons in the adult dentate
gyrus (DG) [14,15]. However, the mechanisms of hypoxia/
ischemia-induced neurogenesis are largely unknown.
Vascular endothelial growth factor (VEGF) plays a crucial role in
neurogenesis [16,17]. VEGF exerts its action via phosphotyrosine
kinase receptors including VEGFR1/fms-like tyrosine kinase (flt)
and fetal liver kinase1 (flk1). VEGF can activate divergent
intracellular signaling components and regulate retinal progenitor
cell proliferation and neuronal differentiation. VEGF can also
mediate the cross-talk between neural stem cells and endothelial cells
[18,19].Transientoxygen and glucosedeprivation(OGD) treatment
enhanced VEGF signaling via regulation of hypoxia-inducible factor
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e22901Figure 1. Neuronal regeneration in the granule cell layer of the hippocampal dentate gyrus of wild type and Cav-1 KO mice.
A. Representative micrographs of the immature neuronal marker, doublecortin (DCX), in the granule cell layer of the hippocampal dentate gyrus of
wild type mice and Cav-1 KO mice. Scale bar=100 mm B. Histograms showing the quantification of DCX positive cells in wild type mice and Cav-1 KO
mice (Mean 6 S.D., n=6). Wild type mice versus Cav-1 KO mice, *** p,0.001. C. Representative image and traces from Sholl analysis of DCX positive
cells with tertiary branches in wild type mice and Cav-1 KO mice. D. Cav-1 KO mice had longer dendrites of DCX positive cells than wild type mice
(Mean 6 S.D., n=6). The number of intersection/dendritic length represents the complexity of the dendrites. Wild type mice versus Cav-1 KO mice,
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regulation of VEGF and flk1 and stimulated the proliferation and
differentiation of adult NPCs in vitro and promoted neurogenesis
in vivo [21,22]. VEGF was found to enhance neurogenesis,
neuromigration, angiogenesis, and to improve the recovery of
neurological deficits and learning ability in the animal models of
focal cerebral ischemic injury and spinal cord injury
[23,24,25,26]. Thus, VEGF signal pathway is critical in brain
repair after ischemic brain injury.
VEGF-induced extracellular signal-regulated kinase (ERK) or
p44/42 mitogen-activated protein kinase (p44/42MAPK) signal-
ing pathways participate in neurogenesis [27]. Hypoxia-reoxy-
genation can up regulate VEGF expression and activate p44/
42MAPK signaling pathways in NPCs [20,28]. Flk1, a VEGF
receptor, mediates the activation of p44/42MAPK and subse-
quently promotes neurite extension in peripheral or central
neurons [29,30]. The activation of p44/42MAPK triggers cell
growth and differentiation [31]. Meanwhile, VEGF increases
neurogenesis and promotes cell survival after traumatic brain
injury in vivo by activating PI3K/Akt signal pathways [17]. Akt
promotes neuronal differentiation of NPCs by regulating the
assembly and activity of neural basic helix-loop-helix (bHLH)
transcription factor complexes [32]. Signal transducer and
activator of transcriptions (STATs), as cytoplasmic transcription
factors, are activated at the plasma membrane by tyrosine
phosphorylation before being translocated into the nucleus to
activate target genes [33]. VEGF-induced reprogramming of
epithelial progenitor cells (EPCs) could promote neurogenesis
through modulating Flk1 expression and phosphorylation of Stat3
[34]. Moreover, Stat3 can be phosphorylated by p44/42MAPK
on Ser-727 in response to growth factors to promote neuronal
differentiation in embryonic stem cells [35,36]. Thus, p44/
42MAPK, Akt and Stat3 are potential target proteins in VEGF-
mediated neuronal growth and differentiation.
Recent progress indicates that caveolin-1 (Cav-1), a 22 kDa
protein located at plasma membrane invaginations, negatively
controls VEGF signaling pathways. Over-expression of Cav-1 can
inhibit flk1 and p44/42MAPK cascade and block VEGF-induced
cell growth signals in endothelial cells [37]. Cav-1 is widely
expressed in neuronal cell types and brain regions [38,39]. Cav-1
decreases neurite outgrowth and branching, and reduces neurite
density in differentiated PC 12 cells [40]. Cav-1 blocks the
formation of neurites and phosphorylation of ERK in bFGF-
treated N2a cells [41]. Our previous study revealed that Cav-1 was
down-regulated in the core and penumbra of ischemic brains [42].
Cav-1 was found in NPCs [43]. Genetic ablation of Cav-1
increased NPCs proliferation in the subventricular zone (SVZ) of
the adult mouse brain [44]. Whether Cav-1 regulates VEGF
signaling pathway and neuronal differentiation of NPCs is still
unknown. In the present study, we conducted a series of
experiments to test the hypothesis that (1) Cav-1 can affect the
differentiation of NPCs by inhibiting VEGF, p44/42 MAPK,
PI3K/Akt and Stat3 signaling pathways in NPCs; (2) Hypoxia can
down-regulate the expression of Cav-1 protein in NPCs, and the
subsequently down-regulation of Cav-1 can activate p44/42
MAPK, PI3K/Akt and Stat3 signaling cascades in a VEGF-
dependent pathway and subsequently promote neuronal differen-
tiation of NPCs.
Results
Cav-1 knockout mice had enhanced neuronal
differentiation of NPCs and VEGF expression in
hippocampal dentate gyrus of brains
In order to elucidate the role of Cav-1 in regulating neuronal
development in vivo, both wild type C57BL/6J mice and Cav-1
knockout mice derived from C57BL/6J strain were used in this
study, and we compared the rates of doublecortin (DCX) positive
cells in the granule cell layer of the hippocampal dentate gyrus,
one of the major areas of neurogenesis. DCX gene encodes a 40-
kDa microtubule-associated protein, which is specifically expressed
in neuronal precursors in the developing and adult CNS. During
CNS development, the DCX expression is associated with the
migration and differentiation of neuronal precursors [54,55]. Thus
DCX was used as a biomarker for detecting neuronal differenti-
ation and development. As shown in Figure 1, Cav-1 knockout
Figure 2. VEGF expression in the granule cell layer of the
hippocampal dentate gyrus of wild type and Cav-1 KO mice.
A, Representative micrographs of VEGF positive cells in the granule cell
layer of the hippocampal dentate gyrus of wild type mice and Cav-1 KO
mice. Arrows indicate the positive cells. Scale bar=100 mm
B, Histograms showing the quantification of VEGF positive cells in wild
type mice and Cav-1 KO mice (Mean 6 S.D., n=6). Wild type mice
versus Cav-1 KO mice, *** p,0.001.
doi:10.1371/journal.pone.0022901.g002
*p,0.05, p,0.01; E. Cav-1 KO mice had higher numbers of intersections of DCX positive cells than wild type mice (Mean 6 S.D., n=6). Wild type
mice versus Cav-1 KO mice, * p,0.05, p,0.01.
doi:10.1371/journal.pone.0022901.g001
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type mice (about 1.9-fold increase) (Fig. 1A, 1B). Moreover, in the
hippocampal dentate gyrus, Cav-1 knockout mice had higher
numbers of DCX-immunoreactive cells with longer tertiary
dendrites than wild type mice (Fig. 1C–1E). In the meantime,
we investigated the expression of VEGF in the hippocampal
dentate gyrus of wild type mice and Cav-1 knockout mice. As
shown in Figure 2, the Cav-1 knockout mice had more abundant
VEGF positive cells than wild type mice (about 2.7-fold increase).
These results indicate that the genetic ablation of Cav-1 directly
promotes the productions and maturations of newborn neurons
and VEGF expression.
Hypoxia-reoxygenation (HR) treatment down-regulated
Cav-1 expression but enhanced neuronal differentiation
in NPCs
Subsequently, we compared the expression of Cav-1 protein
and neuronal differentiation of NPCs under normoxic and HR
conditions. Tuj-1 is a commonly used neuronal biomarker. By
Figure 3. Dynamic changes of Cav-1 and differentiation of NPCs under normoxic and hypoxia-reoxygenation conditions. For
hypoxia-reoxygenation (HR) treatment, NPCs were exposed 1% to O2 for 24 h and then switched to 21% O2 for 1, 3, 7, and 14 days, while for
normoxic treatment, NPCs were consistently cultured under normoxia with 21% O2. Neuronal differentiation was identified by using Tublin b-III (Tuj-
1). The fluorescent images were obtained with Carl Zeiss Axio Observer Z1 fluorescent imaging system. A. Representative immunofluorescent
imaging of Tuj-1 and Cav-1 in NPCs: Red color: Tuj-1 staining; Green color: Cav-1 staining. Nuclear localization of Tuj-1 and Cav-1 was verified by
co-localization with DAPI staining (blue color). B. Statistical analysis on the relative percentage of Cav-1 and Tuj-1 positive cells in NPCs
(Mean 6 S.D., n=5). Hypoxia versus Normoxia at same time points, ** p,0.01; Observed day versus day 1 under the same oxygen condition, #
p,0.05; ## p,0.01.
doi:10.1371/journal.pone.0022901.g003
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dynamic changes of Cav-1 expression and neuronal differentiation
in NPCs after the cells were exposed to hypoxia with 1% O2 for
24 h and switched to normoxia with 21% O2 for 1, 3, 7 and 14
days. As shown in Figure 3(A, B), the expression of Cav-1 was
increased in normoxic NPCs but decreased in HR-treated NPCs.
Simultaneously, HR-treated NPCs had higher level of Tuj-1
expression than normoxic NPCs. Subsequently, by co-immuno-
staining of a mature neuronal marker neurofilament 200 (NF200)
and glial marker glial fibrillary acidic protein (GFAP), we further
identified the formations of neurons and glial cells derived from
NPCs, respectively. As shown in Figure 4 (A, B), HR treatment
promoted the maturation of neuronal cells but induced a less
intense increase in the formation of glial cells in comparison to the
normoxic condition. In the meantime, compared with normoxic
NPCs, HR-treated NPCs had no significant changes in both Ki-67
Figure 4. Neuronal and astroglial differentiation of NPCs under normoxic and hypoxia-reoxygenation conditions. For HR treatment,
NPCs were exposed 1% to O2 for 24 h and then switched to 21% O2 for 1, 3, 7, and 14 days, while for normoxic treatment, NPCs were consistently
cultured under normoxia with 21% O2. Neuronal differentiation was identified by using NF200 whereas glial differentiation was observed by
detecting GFAP expression. The fluorescent images were obtained with Carl Zeiss Axio Observer Z1 fluorescent imaging system. A. Representative
immunofluorescent imaging of Neurofilament 200 (NF 200) and glial fibrillary acidic protein (GFAP) in NPCs. Red color: NF200
staining; Green color: GFAP staining. Nuclear localizations of NF200 and GFAP were verified by co-localization with DAPI staining (blue color). B.
Statistical analysis on the relative percentage of GFAP and NF200 positive cells in NPCs (Mean 6 S.D., n=6). Hypoxia versus normoxia at
same time points, * p,0.05, ** p,0.01; Observed day versus day 1 under the same oxygen condition, # p,0.05, ## p,0.01.
doi:10.1371/journal.pone.0022901.g004
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Similarly, immunoblot analysis (Fig. 7A, B) revealed that the
expression levels of Cav-1 protein in normoxic NPCs at 1, 3, 7 and
14 days were gradually increased but were significantly decreased
in HR-treated NPCs at day 7 and day 14. The expression of Tuj-1
was markedly enhanced at day 7 and day 14 in both normoxic and
HR-treated NPCs. HR treatment induced a relatively higher level
of Tuj-1 expression than normoxic treatment at day 7 and day 14.
Consistent with GFAP fluorescent staining, HR treatment induced
a less intense increase in the expression of GFAP protein at day 7
and day 14 in comparison to the normoxic condition. There was
no statistical change in the expression of nestin between normoxic
NPCs and HR-treated NPCs. These results suggest that the down-
regulation of Cav-1 protein might be associated with enhanced
neuronal differentiation instead of promoting proliferation and
inducing apoptosis in HR-treated NPCs.
Hypoxia-reoxygenation (HR) treatment promoted VEGF
expression, p44/42 MAPK phosphorylation and neuronal
differentiation in NPCs
We next compared the phosphorylations of p44/42MAPK, Akt,
Stat3 in normoxic and HR-treated NPCs (Fig. 7A, 7B, Fig. S1).
Immunoblot analysis revealed that the phosphorylation of p44/
42MAPK was up-regulated at day 7 and 14 in both normoxic and
HR-treated NPCs. The HR-treated NPCs had a significant higher
phosphorylation level of p44/42MAPK than normoxic NPCs.
Meanwhile, the phosphorylation of Akt had no significant change
Figure 5. The proliferation of NPCs under normoxic and hypoxia-reoxygenation conditions. For HR treatment, NPCs were exposed 1% to
O2 for 24 h and then switched to 21% O2 for 1, 3, 7, and 14 days, while for normoxic treatment, NPCs were consistently cultured under normoxia with
21% O2. A. Representative immunofluorescent imaging of Ki-67 in NPCs. Red color: Ki-67 staining; Nuclear localization of Ki-67 was verified
by co-localization with DAPI staining (blue color). B. Statistical analysis on the relative percentage of Ki-67 positive cells in NPCs (Mean 6
S.D., n=6). Observed day versus day 1 under the same oxygen condition, ## p,0.01.
doi:10.1371/journal.pone.0022901.g005
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significantly up-regulated at day 14 in both normoxic and HR-
treated NPCs. Compared with normoxic NPCs, HR-treated NPCs
had no effect on the phosphorylation of Stat3 in the current
experimental condition.
By co-immunostaining of VEGF and DAPI, we investigated the
intracellular levels of VEGF in both normoxic and HR-treated NPCs
with fluorescent microscopy. Figure 8 showed that HR treatment
promoted VEGF expression in NPCs (Fig. 8A, 8B). We subsequently
determined the levels of secreted VEGF in the differentiation
medium. Consistently, the ELISA experiments showed that the level
of VEGF was increased in both normoxic and HR-treated NPCs.
The HR-treated NPCs had a remarkable higher level of VEGF than
normoxic NPCs at day 7 and day 14 (Fig. 8C). These results suggest
that hypoxia-reoxygenation treatment can induce the up-regulation
in the phosphorylation of p44/42MAPK and VEGF expression, and
promote neuronal differentiation of NPCs.
Cav-1 manipulations regulate neuronal differentiation
and expressions of VEGF, flk1, phosphorylations of p44/
42MAPK, Akt and Stat3 in normoxic NPCs
To explore the impact of Cav-1 on the VEGF expression,
phosphorylations of p44/42MAPK, Akt, Stat3 and neuronal
differentiation, we artificially manipulated the level of Cav-1 and
determined the expression of Tuj-1 in NPCs under normoxic
condition. The cells were treated with a Cav-1 scaffolding domain
peptide (Cav-1 peptide) or a Cav-1 scrambled control peptide
Figure 6. The apoptosis of NPCs under normoxic and hypoxia-reoxygenation conditions. For HR treatment, NPCs were exposed 1% to O2
for 24 h and then switched to 21% O2 for 1, 3, 7, and 14 days, while for normoxic treatment, NPCs were consistently cultured under normoxia with
21% O2. A. Representative immunofluorescent imaging of Cleaved caspase-3 in NPCs. Green color: Cleaved caspase-3 staining; Nuclear
localization of Cleaved caspase-3 was verified by co-localization with DAPI staining (blue color). B. Statistical analysis on the relative
percentage of Cleaved caspase-3 positive cells in NPCs (Mean 6 S.D., n=6).
doi:10.1371/journal.pone.0022901.g006
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PLoS ONE | www.plosone.org 8 August 2011 | Volume 6 | Issue 8 | e22901(control peptide). Since day 14 had remarkably the enhanced
neural differentiation and the decreased Cav-1 level in HR-treated
NPCs, we particularly selected day 14 for the experiments. The
treatment of Cav-1 peptide, instead of control peptide, remarkably
inhibited neuronal differentiation (Fig. 9A, Fig. 9C, Fig. 10) and
down-regulated the expressions of VEGF and its receptor flk1
Figure 8. Expression of VEGF in NPCs treated with normoxia and hypoxia-reoxygenation. For HR treatment, NPCs were exposed 1% to
O2 for 24 h and then switched to 21% O2 for 1, 3, 7, and 14 days, while for normoxic treatment, NPCs consistently cultured under normoxia with 21%
O2. A. Representative immunofluorescent imaging of VEGF expression in NPCs: Green color: VEGF staining. Nuclear localization of VEGF
was verified by co-localization with DAPI staining (blue color). B. Statistical analysis on the relative percentage of VEGF positive cells in
NPCs (Mean 6 S.D., n=6). Hypoxia versus normoxia at same time points, * p,0.05, ** p,0.01; Observed day versus day 1 under the same
oxygenation condition, # p,0.05, ## p,0.01. C. ELISA detection of VEGF concentrations in culture media from normoxic and hypoxic
NPCs. Cell culture supernatants were collected from the normoxic and hypoxic NPCs at 0, 1, 3, 7 and 14 days. VEGF was detected with ELISA
immunoassay kit (R&D systems) according to manufacturer’s protocol (Mean 6 S.D., n=3). Hypoxia versus normoxia at same time points, ** p,0.01;
Observed day versus day 0 under the same oxygenation condition, ## p,0.01. Each sample was measured in duplicate.
doi:10.1371/journal.pone.0022901.g008
Figure 7. Western blot analysis on the expressions of Cav-1, Tuj-1, GFAP, nestin, p-p44/42MAPK, p-Akt and p-Stat3 proteins in
NPCs under normoxic and hypoxia-reoxygenation conditions. For HR treatment, NPCs were exposed 1% to O2 for 24 h and then switched to
21% O2 for 1, 3, 7, and 14 days, while for normoxic treatment, NPCs consistently cultured under normoxia with 21% O2. A. Representative
immunoblot detections for the expressions of Cav-1, Tuj-1, GFAP, nestin, p-p44/42MAPK, p-Akt and p-Stat3. Cell lysates were blotted
with antibodies including Cav-1, Tuj-1, GFAP, nestin, p-p44/42 MAPK, p-Akt, and p-Stat3, in which b-actin, p44/42 MAPK, Akt and Stat3 were used as
internal references, respectively. B. Statistical analysis on the expressions of Cav-1, Tuj-1, GFAP, nestin, p-p44/42MAPK and p-Stat3
(Mean 6 S.D., n=3). Expressions of Cav-1, Tuj-1, GFAP and nestin were presented as fold activation of light units normalized to b-actin, whereas the
phosphorylations of p44/42MAPK, Akt, and Stat3 were presented as the fold activations of light units normalized to p44/42MAPK, Akt and Stat3,
respectively; Hypoxia versus normoxia at same time points, * p,0.05, ** p,0.01; Observed day versus day 1 under the same oxygenation condition,
# p,0.05, ## p,0.01. Each sample was assayed at least 3 times.
doi:10.1371/journal.pone.0022901.g007
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remarkably down-regulated the phosphorylations of p44/
42MAPK, Akt, and Stat3 in NPCs (Fig. 10, Fig.S2). We further
investigated the relationship between Cav-1 expression and
neuronal differentiation in NPCs by knocking down Cav-1 with
an RNA silencing approach. The RNAi treatment resulted in
about 65% inhibition in the expression of Cav-1 (Fig. 11A). By co-
immunostaining of VEGF, Tuj-1 and DAPI, we found that the
knockdown of Cav-1 significantly up-regulated the expressions of
VEGF and Tuj-1 (Fig. 11A, 11B). Immunoblot analysis further
confirmed that Cav-1 RNAi treatment not only promoted VEGF
expression and neuronal differentiation of NPCs but also up-
regulated the phosphorylations of p44/42MAPK, Akt, and Stat3
in normoxic NPCs (Fig. 12A, 12B, Fig. S3).
We then investigated the roles of VEGF signaling in the
regulation of neuronal differentiation induced by Cav-1. To
achieve this goal, we observed the effects of VEGF specific
inhibitor (V1) on Tuj-1 expression in the Cav-1 RNAi-treated
NPCs. V1 is a dimerized peptide derived from the third Ig-like
domain of the human vascular endothelial growth factor receptor-
2 (KDR/Flk1) comprising residues 247–261 [56,57]. V1 can bind
to VEGF and block its interaction with VEGFR-2 and the
autophosphorylation of VEGFR-2 [58,59]. As expected, VEGF
inhibitor abolished the Cav-1 RNAi-induced up-regulations in the
phosphorylations of p44/42MAPK, Akt, Stat3 and the neuronal
differentiation of NPCs (Fig. 12A, 12B, Fig. S3). On the other
hand, we also investigated the effects of Cav-1 scaffolding domain
peptide on VEGF-induced neuronal differentiation. The results
Figure 9. Effects of Cav-1 scaffolding domain peptide on the expressions of Tuj-1 and VEGF in NPCs under normoxic condition. Cells
were consistently incubated in a standard incubator with humidified 21% O2 plus 5% CO2 balanced with N2 for 14 days. Cells were cultured with fresh
medium containing a synthetic cell-permeable peptide encoding Cav-1 scaffolding domain (amino acids 82 to 101, DGIWKASFTTETVTKYWFYR) or a
Cav-1 scrambled control peptide (WGIDKAFFTTSTVTYKWFRY) with Antennapedia internalization sequence (RQIKIWFQNRRMKWKK) at a final
concentration of 4 mM. The medium was changed every two days and lasted for 14 days. A–B. Representative immunofluorescent imaging of
Tuj-1 and VEGF in NPCs at day 14. Red color: Tuj-1 and VEGF staining; Tuj-1 and VEGF staining (red color) were identified in blank control group
(a, b, c), control peptide group (d, e, f) and Cav-1 peptide group (g, h, i). Nuclear localizations of Tuj-1 and VEGF were verified by co-localization with
DAPI staining (blue color). C–D. Statistical analysis on the relative percentage of Tuj-1 and VEGF positive cells in NPCs (Mean 6 S.D.,
n=6). Blank, blank control group; Con P, Cav-1 scrambled control peptide group; Cav P, Cav-1 scaffolding domain peptide group. Cav P versus blank,
** p,0.01; Cav P versus Con P, ## p,0.01.
doi:10.1371/journal.pone.0022901.g009
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of NPCs as showed by Tuj-1 expression, but the neurogenesis-
promoting effects of VEGF were remarkably inhibited by Cav-1
peptide treatment (Fig. 13). These results provide direct evidence
that Cav-1 can inhibit neuronal differentiation of NPCs via the
down-regulations of VEGF/flk1 and its downstream signaling
molecules including p44/42MAPK, Akt and Stat3.
Cav-1 manipulations affect neuronal differentiation and
expressions of VEGF, flk1, phosphorylations of p44/
42MAPK, Akt and Stat3 in HR-treated NPCs
Finally, by using similar approaches to normoxic experiments,
we further investigated the roles of Cav-1 in modulating neuronal
differentiation in HR-treated NPCs. NPCs were exposed to
hypoxia with 1% O2 for 24 h and then changed to normoxic
condition with 21% O2 for 1, 3, 7 and 14 days. Prior to hypoxic
treatment, the NPCs were pretreated with Cav-1 scaffolding
domain peptide or Cav-1 scrambled control peptide and the cells
were continuously incubated with the peptides for 14 days. As
showed in Figure 14 and 15, the treatment of Cav-1 peptide
markedly down-regulated the expressions of VEGF and flk1,
phosphorylations of p44/42MAPK, Akt, Stat3, and inhibited
neuronal differentiation in HR-treated NPCs. In contrast, the
treatment of Cav-1 RNAi significantly up-regulated the phos-
phorylations of p44/42MAPK, Akt, Stat3 and promoted neuronal
differentiation, whereas the co-treatment of V1 blocked the effects
of RNAi in the transient hypoxic NPCs (Fig. 16). In particular,
Cav-1 RNAi led to more than 3-fold increase in the phosphor-
ylation of Stat3, but this increase was completely abolished by co-
treatment of V1. Taken together, these results strongly suggest that
hypoxia-induced down-regulation of Cav-1 expression contributes
to the enhanced neuronal differentiation of NPCs via up-
regulation of VEGF signaling and phosphorylations of p44/
42MAPK, Akt, Stat3.
Discussion
In the present study, we report for the first time that: (1) Cav-1
knockout mice had more abundant newborn neurons and higher
VEGF expression than wild type mice; (2) Cav-1 inhibited
neuronal differentiation of NPCs via the down-regulation of
VEGF signaling and the inhibition of p-p44/42MAPK, p-Akt and
p-Stat3; (3) Hypoxia down-regulated the expression of Cav-1, up-
regulated VEGF and p-p44/42MAPK, subsequently promoting
neuronal differentiation of NPCs. Our results suggest that the
hypoxia-induced down-regulation of Cav-1 and subsequent
activation of VEGF/flk1 and p44/42MAPK signaling pathways
contribute to neuronal differentiation of neural progenitor cells.
Cav-1 functions as a negative regulator of tissue or cell
regeneration. Previous study indicate that the down-regulation of
Cav-1 can activate ERK and p44/42MAPK signaling pathway
and affect proliferation and migration of myogenic precursor cells
(MPCs) toward the wounded area [60]. Genetic ablation of Cav-1
increases NPCs proliferation in the subventricular zone (SVZ) of
the adult mouse brain [44]. Herein, we found that Cav-1 knockout
mice had more abundant DCX and VEGF positive staining cells
in the hippocampal dentate gyrus than wild type mice, and that
the loss of Cav-1 was associated with the enhanced VEGF
expression and neuronal differentiation of NPCs. The results
provide a clue that Cav-1 might play a role in regulating VEGF
signaling and neuronal differentiations.
VEGF and its receptor flk1 can improve the extension of neural
stem/progenitor cells [22,61]. Flk1 receptor tyrosine kinase is the
major mediator of VEGF-dependent signaling. The induction of
VEGF/Flk1 stimulates the binding, phosphorylation and activa-
tions of multiple downstream signal molecules such as MAPK,
PKC, PI3K-Akt, etc [62,63,64,65]. We found that hypoxia-
reoxygenation treatment remarkably down-regulated the expres-
sion of Cav-1, up-regulated the expression of VEGF and
phosphorylation of p44/42MAPK, and increased the expression
of Tuj-1 in NPCs. One may argue that the potential effects of
hypoxia-reoxygenation on the proliferation and apoptosis of NPCs
might affect the experimental results. To address this, we stained
Ki-67 and Cleaved caspase-3 positive cells and measured the
expression of nestin in both normoxic and HR-treated NPCs. Our
results revealed that hypoxia-oxygenation treatment did not
change the numbers of Ki-67 positive and Cleaved caspase-3
positive cells, and nestin expression. Those results suggest that
Figure 10. Effects of Cav-1 scaffolding domain peptide on the
expressions of Tuj-1, flk1, p-p44/42MAPK, p-Akt and p-Stat3
proteins in NPCs under normoxic condition. Similar protocols as
Figure 7 were used. Expressions of Tuj-1, flk1, p-p44/42MAPK, p-Akt and
p-Stat3 proteins in NPCs at day 14 were analyzed with western blot
analysis. Cell lysates were blotted with the antibodies of Tuj-1, flk1, p-
p44/42MAPK, p-Akt, and p-Stat3, in which b-actin, p44/42MAPK, Akt
and Stat3 were used as internal references, respectively. A. Represen-
tative immunoblot results of Tuj-1, flk1, p-p44/42MAPK, p-Akt
and p-Stat3. Blank, blank control group; Con P, Cav-1 scrambled
control peptide group; Cav P, Cav-1 scaffolding domain peptide group.
B. Statistical analysis on the expressions of Tuj-1, flk1, p-p44/
42MAPK, p-Akt and p-Stat3 (Mean 6 S.D., n=3). The expressions of
Tuj-1 and flk1 were presented as fold activation of light units
normalized to b-actin, whereas the phosphorylations of p44/42MAPK,
Akt, and Stat3 were presented as fold activations of light units
normalized to p44/42MAPK, Akt and Stat3, respectively. Cav P versus
blank, * p,0.05, ** p,0.01; Cav P versus Con P, # p,0.05, ## p,0.01;
Each sample was assayed at least 3 times.
doi:10.1371/journal.pone.0022901.g010
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VEGF and p44/42MAPK signaling, and promote neuronal
differentiation of NPCs.
Cav-1 can serve as a scaffold for a variety of signaling
complexes. The presence of a Cav-1 domain corresponding to
amino acids 82–101 can interact with consensus motifs present in
VEGF and its receptor flk1 [66]. To address the intrinsic
relationship between the down-regulation of Cav-1 and the
differentiation of NPCs, we chose to use Cav-1 scaffolding domain
peptide and Cav-1 RNAi in the normoxic and hypoxic
experiments. Cav-1 scaffolding domain peptide remarkably
inhibited the expressions of VEGF, flk1, phosphorylation of
p44/42MAPK and neuronal differentiation of NPCs. Cav-1
scaffolding domain peptide directly abolished the VEGF-induced
neuronal differentiation. On the other hand, Cav-1 RNAi
promoted the expressions of VEGF, flk1 and the phosphorylation
of p44/42MAPK and neuronal differentiation NPCs under both
normoxic and hypoxic conditions. Interestingly, VEGF inhibitor
Figure 11. Effects of siRNA Cav-1 specific knockdown on the expressions of Tuj-1, VEGF in NPCs with or without V1 treatment
under normoxic condition. A short interfering RNA transfection was used to knock down the expression of Cav-1 in NPCs. NPCs were transfected
with Cav-1 Stealth
TM RNAi. All data were obtained at day 14. A. Representative results of the expressions of Cav-1, Tuj-1 and VEGF. Left, the
expression of Cav-1 was successfully knocked down by the Cav-1 RNAi; Right, immunofluorescent imaging of VEGF and Tuj-1, Green color: VEGF
staining. Red color: Tuj-1 staining. Nuclear localization of VEGF and Tuj-1 was verified by co-localization with DAPI staining (blue color). NC, negative
control group; siCav-1, Cav-1 RNA silencing group; B. Statistical analysis on the relative percentage of VEGF and Tuj-1 positive cells in
NPCs (Mean 6 S.D., n=6). siCav-1 versus NC, **p,0.01.
doi:10.1371/journal.pone.0022901.g011
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phosphorylations of p44/42MAPK, Akt, Stat3 and the neuronal
differentiation of NPCs. These results indicate that Cav-1 specially
inhibits neuronal differentiation of NPCs through modulating
VEGF/flk1 expressions and phosphorylation of p44/42MAPK.
There is an avenue to mention that neuronal differentiation is
complex and multiple signal pathways involve in the process. The
down-regulation of VEGF/flk1 could be due to the direct effects of
Cav-1 or indirect mechanisms via regulating other molecular
cascades. For example, NO is known to promote the expression of
VEGF whereas Cav-1 can inhibit endothelial nitric oxide synthase
(eNOS) activity and decrease NO release [67,68]. Thus, down-
regulation of VEGF could be explained by the indirect roles of
Cav-1 on NO production. In addition, our recent study revealed
that Cav-1 peptide could regulate Notch signaling in NPCs [69].
Notch-Hes1 served as a convergent signaling node within early
retinal progenitor cells to integrate cell-extrinsic cues such as
VEGF and sonic hedgehog (SHH), to regulate cell proliferation
and neuronal specification [18]. The interaction of Notch and
VEGF might contribute to the molecular regulations of Cav-1 on
VEGF signaling and neuronal differentiation. Therefore, we
remark that Cav-1 plays a crucial role in inhibiting VEGF
signaling and neuronal differentiation of NPCs. The down-
regulation of Cav-1 contributes to the enhanced VEGF/flk1
expressions and p44/42MAPK phosphorylation and neurogenesis
in hypoxia-reoxygenation-treated NPCs.
It is well known that Stat3 and Akt play important roles in
growth factors-induced neuronal differentiation [70,71]. Here, we
found that the phosphorylations of Akt and Stat3 were down-
regulated by Cav-1 peptide but up-regulated by Cav-1 RNAi in
normoxic and hypoxic NPCs, suggesting that Cav-1 can inhibit
activities of Akt and Stat3. However, exposure to 1% O2 did not
induce a significant difference in the phosphorylations of Akt and
Stat3 although hypoxic treatment induced the phosphorylation of
p44/42MAPK. One feasible explanation could be that, although
hypoxic treatment down-regulated Cav-1, the down-regulation of
Cav-1 did not reach a point where phosphorylations of Akt and
Stat3 were enhanced in NPCs. Moreover, we found that VEGF
inhibitor (V1) completely abolished Cav-1 RNAi induced up-
regulation in the phosphorylations of Akt and Stat3 in normoxic
and hypoxic NPCs. As different phosphorylation sites may carry
different functions, we also measured the effect of Cav-1 on the
phosphorylations of Stat3 at the sites of Tyr 705 and Ser 727. Data
showed that Cav-1 could negatively modulate phosphorylation of
Stat3 at both serine and tyrosine sites. Especially, VEGF inhibitor
abolished the enhanced phosphorylation of Stat3 at both serine
and tyrosine sites in the Cav-1 RNAi-treated NPCs. These results
imply that the Cav-1-induced inhibition of Akt and Stat3 signaling
are VEGF dependent.
In conclusion, we report that Cav-1 can inhibit VEGF and its
downstream p44/42 MAPK, Akt and Stat3 signaling pathways
and modulate neuronal differentiation. The down-regulation of
Cav-1 gene expression induced by hypoxia could improve
neuronal differentiation of NPCs. Our data provide a potential
explanation why hypoxia could enhance neuronal differentiation.
These findings represent an important advance in understanding
the signal pathways in the modulation of neurogenesis. Thus, Cav-
1 could be developed into a novel therapeutic target protein for
promoting neurogenesis for the treatment of stroke and neurode-
generative diseases in the future.
Materials and Methods
Animals
Cav-1 knockout mice (Cav-1 KO; Cav1 tm1Mls/J, Jackson
Laboratory, Bar harbor, ME, USA) from heterozygote breedings
were genotyped and used for the experiments. Wild type C57BL/
6J mice and Sprague-Dawley (SD) rats were obtained from
Laboratory Animal Unit at the University of Hong Kong. The
experimental protocol was approved by the institutional Animal
Care and Ethical Committee at the University of Hong Kong
(Approved No. 1479-07, 1844-09). Every effort was made to
minimize the number of animals used and their suffering. The
animals were maintained at a controlled temperature (2062uC)
Figure 12. Effects of siRNA Cav-1 specific knockdown on the
expressions of Tuj-1, p-p44/42MAPK, p-Akt and p-Stat3 in
NPCs with or without V1 treatment under normoxic condition.
A short interfering RNA transfection was used to knock down the
expression of Cav-1 in NPCs. NPCs were transfected with Cav-1
Stealth
TM RNAi. All data were obtained at day 14. A. Representative
immunoblot results for the expressions of Tuj-1, p-p44/
42MAPK, p-Akt and p-Stat3 in NPCs treated by Cav-1 specific
knockdown with or without V1 treatment. VEGF inhibitor V1
(12 mM) was used to treat NPCs prior to transfection of Cav-1 Stealth
TM
RNAi. Cell lysates were blotted with the antibodies for Tuj-1, p-p44/42
MAPK, p-Akt, and p-Stat3, in which b-actin, p44/42MAPK, Akt and Stat3
were used as internal references, respectively. NC, negative control
group; siCav-1, Cav-1 RNA silencing group; siCav-1+V1: Cav-1 RNA
silencing+V1 group; B. Statistical analysis on the expressions of
Tuj-1, flk1, p-p44/42MAPK, p-Akt and p-Stat3 (Mean 6 S.D.,
n=3). The expression of Tuj-1 was presented as fold activation of light
units normalized to b-actin, whereas the phosphorylations of p44/
42MAPK, Akt, and Stat3 were presented as the fold activations of light
units normalized to p44/42MAPK, Akt and Stat3, respectively. Cav-1
siRNA versus negative control, * p,0.05, ** p,0.01; Cav-1 siRNA+V1
versus Cav-1 siRNA, # p,0.05, ## p,0.01; Each sample was assayed at
least 3 times.
doi:10.1371/journal.pone.0022901.g012
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water ad libitum.
Tissue processing and Immunohistochemistry
Wild-type and Cav-1 knockout (KO) mice at the age of 9 week
old were deeply anesthetized with a ketamine/xylazine mixture
solution, and then perfused transcardially with 0.05 M sodium
phosphate-buffered saline (pH 7.4), followed by 4% paraformal-
dehyde in 0.05 M sodium phosphate-buffered saline (pH 7.4).
Brains were removed and post-fixed overnight at 4uC. The brain
tissues were then cryoprotected via 24 h immersion in 30%
sucrose and cut into 40 mm sagittal sections. The brain sections
were blocked with a solution containing 0.01 M PBS, 0.1% Triton
X-100 and 5% normal goat serum solution for 30 min, and
subsequently incubated overnight with rabbit anti-doublecortin
(1:500, DCX, Cell signal) and rabbit anti-VEGF (1:50, Santa
Cruz), respectively diluted in blocking solution. Sections were then
washed extensively and incubated with secondary antibody (1:200)
and avidin-biotin complex using the Elite vectastain kit (Vector
Laboratories, Burlingame, CA, USA). Chromogen reactions were
performed with diaminobenzidine (DAB; sigma) and 0.1% H2O2
for 10 min. The sections were cover-slipped with Canada balsam
(Sigma). Negative control groups were simultaneously performed
by omitting primary antibodies to exclude the presence of non-
specific staining.
To determine the number of DCX-positive cells in the
hippocampus, every 12th sections (480 mm intervals) were
selected from one cerebral hemisphere in each animal and
processed for immunohistochemistry. The DCX-positive cells in
the granule cell layer of the hippocampal dentate gyrus were
manually counted using Stereo Investigator software (Version
8.11, Micro-Bright Field) with an automated stage by an
experimenter blinded to the identities of animals. The amount
of cells counted was then extrapolated to get an approximated
value for whole brain. Dendritic complexity of DCX positive cells
including dendritic length and number of intersections (branch
points) in the granule cells layer of the hippocampal dentate gyrus
were analyzed and calculated using Neurolucida software and
NeuroExplorer software (Micro-Bright Field Biotechnology)
[45,46]. Dendritic length means the total dendritic length
between the starting and ending radius [47]. Intersections
represent total number of intersections between the specific
concentric circles and the dendrites. A higher value in dendritic
length or intersections represents a neuron with more complex
dendritic branches. For the quantification of VEGF expression,
six VEGF-immunostained coronal sections at 480 mm intervals
Figure 13. Effects of Cav-1 scaffolding domain peptide on the expression of Tuj-1 in NPCs treated with VEGF under normoxic
condition. Cells were consistently incubated with fresh medium containing VEGF (10 ng/ml) and a Cav-1 scaffolding domain peptide (4 mM) or a
Cav-1 scrambled control peptide (4 mM) with Antennapedia internalization sequence in a standard incubator at humidified 21% O2 plus 5% CO2
balanced with N2. The medium was changed every 2 days and cells were cultured for 14 days. All data were obtained from the samples at day 14.
A. Representative immunoblot results for the expressions of Tuj-1. Cell lysates were blotted with the Tuj-1 antibody, in which b-actin was
used as internal reference. Con P, Cav-1 scrambled control peptide; Cav P, Cav-1 scaffolding domain peptide. B. Statistical analysis on the
expression of Tuj-1. (Mean 6 S.D., n=3). Cav P versus Con P, VEGF+Con P and VEGF+Cav P, ** p,0.01; VEGF+Con P versus Con P, Cav P and
VEGF+Cav P, ## p,0.01; VEGF+Cav P versus VEGF +Con P, Con P and Cav P, DD p,0.01.
doi:10.1371/journal.pone.0022901.g013
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section were digitized under a 406 objective (Olympus BX51).
The images obtained were analyzed by mean of Image J software
(NIH, USA) [48,49] and data were presented as the total
numbers of VEGF immunoreactive cells within each field.
Preparation of Fetal NPCs
NPCs were prepared from the cortex of embryonic E15-16 SD
rats as previously described [50,51]. Briefly, embryonic rats were
deeply anesthetized with a ketamine/xylazine mixture solution,
and then rat embryos were dissected and put into PBS containing
100 U/ml penicillin/streptomycin. The telencephalons were
isolated. Fresh cerebrums were mechanically disrupted into single
cells by filtering through a nylon mesh of 70 mm. After
centrifugation at 10006g for 5 min at 4uC, cells were re-
suspended in serum-free Dulbecco’s modified Eagle’s medium/
Ham’s F12 medium (DMEM/F12; Invitrogen). Dissociated cells
were seeded at a density of 1610
5cells/ml in DMEM/F12
replenished with 2% B27 (Invitrogen), recombinant human basic
fibroblast growth factor (bFGF 10 ng/ml; Sigma), and epidermal
growth factor (EGF 10 ng/ml; Sigma). Cells were incubated in a
humidified atmosphere containing 5% CO2 at 37uC. Fresh culture
medium containing the same concentration of trophic factors was
added twice weekly. The purity of NPCs was verified to be .90%
with nestin staining. Spheres appeared within a few days and were
grown for 3–5 days before collecting them for passage. After one
passage, cells were used for the experiments.
Hypoxia/reoxygenation treatment
Isolated NPCs were re-suspended and cultured in Neurobasal
medium containing 2% B27 and 0.2 mM L-glutamine, as in a
multiple-well plate and then transferred into a modular incubator
chamber. For normoxic treatment, NPCs were consistently
cultured under normoxia with 21% O2. For hypoxia-reoxygena-
tion treatment, NPCs were consistently incubated with 1% O2 plus
5% CO2 balanced with N2 for 24 h. After hypoxic treatment, the
cells were returned to a standard incubator with the normoxic
condition of humidified 95% air/5% CO2. During the experi-
ments, the O2 concentration was monitored with PA-10A
paramagnetic O2 analyzer (sable systems international). According
to the designed experimental plans, we collected the cell samples at
day 1, 3, 7 and 14 after the cells were exposed to 24 hours of
normoxic or hypoxic treatments. Day 0 was defined as the onset
after cells were exposed for 24 hours of normoxic or hypoxic
treatments.
Manipulations of Cav-1 and VEGF
To elucidate the effects of Cav-1 in regulating neuronal
differentiation, a synthetic cell-permeable peptide encoding Cav-
1 scaffolding domain (amino acids 82 to 101, DGIWKASFT-
TETVTKYWFYR) or the Cav-1 scrambled control peptide
(WGIDKAFFTTSTVTYKWFRY) with Antennapedia internali-
zation sequence (RQIKIWFQNRRMKWKK) was custom syn-
thesized by SBS Biotech Co. as previously described [52]. A 10-
mM stock solution was prepared with 100% DMSO and 4 mMo f
peptides was diluted in cultured medium. Fresh medium
containing Cav-1 scaffolding domain peptide or Cav-1 scrambled
control peptide was used to treat NPCs for 14 days. In a parallel
group, fresh medium containing VEGF (Peprotech, 10 ng/ml)
with Cav-1 scaffolding domain peptide or Cav-1 scrambled
control peptide was used to treat NPCs for 14 days. On the other
hand, short interfering RNA transfection was used to particularly
knockdown the expression of Cav-1 in NPCs. Cav-1 and control
siRNA were obtained from Invitrogen [53]. The Cav-1 Stealth
TM
RNAi provides non-overlapping Stealth
TM RNAi duplex for this
gene to obtain high knock-down efficiency. The duplex was
transfected into NPCs with Lipofectamine RNAiMAX (Invitro-
gen). The Cav-1 stealth
TM RNAi duplex was added at a
concentration of 13 nM. A stealth
TM RNAi negative control
duplex (Invitrogen) was used as control. To address whether roles
of Cav-1 in the inhibition of NPCs is related to VEGF dependent
signaling pathway, a VEGF inhibitor (V1, 12 mM) was also used to
treat NPCs prior to transfection of Cav-1 Stealth
TM RNAi.
Figure 14. Effects of Cav-1 scaffolding domain peptide on the
expressions of Tuj-1, flk1, p-p44/42MAPK, p-Akt and p-Stat3
proteins in NPCs under hypoxia-reoxygenation condition. NPCs
were cultured with fresh medium containing a synthetic cell-permeable
Cav-1 scaffolding domain peptide (4 mM) or a Cav-1 scrambled control
peptide (4 mM). For hypoxia-reoxygenation treatment, cells were
exposed 1% O2 for 24 h and then switched to normoxia with fresh
medium for 14 days. All data were obtained from the samples at day 14.
A. Representative results of immunoblot analysis for the
expressions of Tuj-1, flk1, p-p44/42MAPK, p-Akt and p-Stat3.
Cell lysates were blotted with the antibodies for Tuj-1, flk1 p-p44/42
MAPK, p-Akt, and p-Stat3, in which b-actin, p44/42MAPK, Akt and Stat3
were used as internal references, respectively. Blank, blank control
group; Con P, Cav-1 scrambled control peptide group; Cav P, Cav-1
scaffolding domain peptide group. B. Statistical analysis on the
expressions of Tuj-1, flk1, p-p44/42MAPK, p-Akt and p-Stat3
(Mean 6 S.D., n=3). The expressions of Tuj-1 and flk1 were presented
as fold activation of light units normalized to b-actin, whereas the
phosphorylations of p44/42MAPK, Akt, and Stat3 were presented as the
fold activations of light units normalized to p44/42MAPK, Akt and Stat3,
respectively. Cav P versus Blank, * p,0.05, ** p,0.01; Cav P versus Con
P, # p,0.05, ## p,0.01. Each sample was assayed at least 3 times.
doi:10.1371/journal.pone.0022901.g014
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The isolated cultured NPCs were plated on the coverslips and
fixed in fresh 4% paraformaldehyde (in PBS, pH 7.2) at room
temperature for 20 min and washed 3 times with PBS (pH 7.2).
The cells were blocked and permeabilized in 10% normal goat
serum plus 0.1% Triton X-100 for 1 h at room temperature. After
blocking, the cells were washed with PBS and then incubated in
primary antibody in PBS containing 10% normal goat serum at
4uC overnight. Primary antibodies included Cav-1 (Rabbit, 1:400,
Cell Signal), VEGF (Rabbit, 1:50, Santa Cruz), GFAP (Rabbit,
1:800, Millipore), Ki-67 (Rabbit, 1:500, Abcam), Cleaved caspase-
3(Asp175) (Rabbit, 1:500, Cell Signal), Tublin b-III (Tuj-1)
(Mouse, 1:300, Covance) and NF200 (Mouse, 1:800, Sigma).
Negative control groups were simultaneously performed by
omitting primary antibodies to exclude the presence of non-
specific immunofluorescent staining. After rinsing with PBS, the
coverslips were incubated with appropriate species-specific Alexa
Fluor 488- or 568-conjugated IgG (1:200, Invitrogen) antibodies in
the dark at room temperature for 1 h. The coverslips were then
incubated in nuclei counterstained with DAPI (49-6-Diamidino-2-
phenylindole, 1 mg/ml) and mounted in fluorescent mounting
medium (Dako). The fluorescence imaging was visualized by using
a Carl Zeiss Axio Observer Z1 fluorescent imaging system. The
images obtained were analyzed by mean of Image J software
(NIH, USA).
Western blot analysis
Proteins were extracted from cell pellets and dissolved in RIPA
cell lysis buffer containing a protease inhibitor cocktail and a
phosphatase inhibitor cocktail (Sigma). Protein concentrations
were determined with a Bradford protein assay kit (Bio-Rad). The
proteins was denatured with reducing buffer (Laemmli) for 10 min
and separated through 8–12% SDS-PAGE gels. After electropho-
resis, the proteins were transferred to polyvinylidene difluoride
Figure 15. Effects of Cav-1 scaffolding domain peptide on the expressions of Tuj-1 and VEGF protein in NPCs under hypoxia-
reoxygenation condition. Similar experimental protocols as Figure 9 were used in the experiments and data were obtained from the samples at
day 14. A–B: Representative immunofluorescent imaging of Tuj-1 and VEGF in the hypoxic NPCs at day 14. Red color: Tuj-1 and VEGF
staining; Tuj-1 and VEGF staining (red color) were identified in blank control group (a, b, c), control peptide group (d, e, f) and Cav-1 peptide group
(g, h, i). Nuclear localizations of Tuj-1 and VEGF were verified by co-localization with DAPI staining (blue color). C–D. Statistical analysis on the
relative percentage of Tuj-1 and VEGF positive cells in NPCs (Mean 6 S.D., n=6). Blank, blank control group; Con P, Cav-1 scrambled control
peptide; Cav P, Cav-1 scaffolding domain peptide group. Cav P versus blank, ** p,0.01; Cav P versus Con P, ## p,0.01.
doi:10.1371/journal.pone.0022901.g015
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were blocked in 5% BSA for 2 h, rinsed, and incubated overnight
at 4uC with primary antibodies in 5% BSA. Primary antibodies
included Tublin b-III (Tuj-1, Mouse, 1:1000, Covance), nestin
(Mouse,1:1000, BD), flk1 (Mouse, 1:800, Sigma), phospho-p44/
42MAPK (Thr202/Tyr204) (Rabbit, 1:1000, Cell Signal), phos-
pho-Stat3 (Tyr705) (Rabbit, 1:1000, Cell Signal), phospho-Stat3
(Ser727) (Rabbit, 1:1000, Cell Signal), phospho-Akt (Ser473)
(Rabbit, 1:1000, Cell Signal) and Cav-1 (Rabbit, 1:1000, Cell
signal). Excess antibodies were removed by washing the mem-
brane with TBS/0.1% Tween-20 and the membranes were
incubated for 1 hr with horseradish peroxidase-conjugated
secondary antibodies. To normalize the amounts of proteins
applied to SDS-PAGE, the membranes initially incubated with
primary and secondary antibodies, were reprobed with b-actin
(Mouse, 1:2000, Sigma), p44/42MAPK (Rabbit, 1:1000, Cell
signal), Akt (Rabbit, 1:1000, Cell signal) and Stat3 (Rabbit, 1:1000,
Cell signal) antibodies as internal references, respectively. The
bands were visualized by advanced chemoluminescence (GE,
Healthcare Life Sciences), recorded by Gel-Doc (Bio-Rad) and the
relative band intensity was quantified by Quantity One software
(Bio-Rad).
ELISA assay
Cell culture supernatants were collected at 0, 1, 3, 7 and 14 days
(n=3, at each time point). A VEGF immunoassay kit (R&D
systems) was used according to manufacturer’s protocol. Absor-
bance was determined using a Bio-Rad microplate reader at
450 nm, reference wavelength at 540 nm.
Statistical analysis
All data were presented as means 6 S.D. Comparisons of
multiple groups were done by one-way analysis of variance
(ANOVA) dependent experimental designs and followed by
Student-Newman-Keuls (S-N-K) test for two group comparisons
within the multiple groups with SPSS 16.0 statistical programs. In
two group designed experiments, comparisons were done by using
unpaired student’s t-test. Significance was set as a probability level
of p,0.05.
Supporting Information
Figure S1 Western blot analysis on the phosphorylation
of Stat3 in NPCs under normoxic and hypoxia-reoxy-
genation conditions. For hypoxia-reoxygenation treatment,
NPCs were exposed 1% to O2 for 24 h and then switched to 21%
O2 for 1, 3, 7, and 14 days, while for normoxic treatment, NPCs
consistently cultured under normoxia with 21% O2. A. Repre-
sentative immunoblot detection for phosphorylation of
Stat3. Cell lysates were blotted with p-Stat3 (Ser 727) antibody, in
which Stat3 were used as internal reference. B. Statistical
analysis on the phosphorylation of Stat3 (Mean 6 S.D.,
n=3). Phosphorylation of Stat3 was presented as fold activation of
light units normalized to Stat3. Observed day versus day 1 under
the same oxygenation condition, ## p,0.01.
(TIF)
Figure S2 Effects of Cav-1 scaffolding domain peptide
on the phosphorylation of Stat3 in NPCs under normoxic
condition. Phosphorylation of Stat3 in NPCs at day 14 were
analyzed with western blot analysis. Cell lysates were blotted with
p-Stat3 (Ser 727) antibody, in which Stat3 was used as internal
reference. A. Representative immunoblot detection for
phosphorylation of Stat3. Blank, blank control group; Con P,
Cav-1 scrambled control peptide group; Cav P, Cav-1 peptide
group. B. Statistical analysis on the phosphorylation of
Stat3 (Mean 6 S.D., n=3). The phosphorylation of Stat3 was
presented as fold activation of light units normalized to Stat3. Cav
P versus blank, ** p,0.01; Cav P versus Con P, ## p,0.01.
(TIF)
Figure S3 Effects of siRNA Cav-1 specific knockdown on
the phosphorylation of Stat3 in NPCs with or without V1
Figure 16. Effects of siRNA Cav-1 specific knockdown on the
expressions of Tuj-1, p-p44/42MAPK, p-Akt and p-Stat3
proteins in NPCs under hypoxia-reoxygenation conditions
with or without V1 treatment. For HR treatment, NPCs were
exposed 1% O2 for 24 h and then switched to normoxia with fresh
medium for 14 days. A short interfering RNA transfection was used to
knock down the expression of Cav-1 in NPCs. NPCs were transfected
with Cav-1 Stealth
TM RNAi. V1 (12 mM) was used to treat NPCs prior to
transfection of Cav-1 Stealth
TM RNAi. All data were obtained at day 14.
A. Representative results of immunoblot analysis for the
expressions of Tuj-1, p-p44/42MAPK, p-Akt, p-Stat3. Cell lysates
were blotted with the antibodies for Tuj-1, p-p44/42MAPK, p-Akt and p-
Stat3 in which the antibodies for b-actin, p44/42 MAPK, Akt and Stat3
were used as internal references, respectively. NC, negative control
group; siCav-1, Cav-1 RNA silencing group; siCav-1+V1: Cav-1 RNA
silencing+V1 group; B. Statistical analysis on the expressions of
Tuj-1, flk1, p-p44/42MAPK, p-Akt and p-Stat3 (Mean 6 S.D.,
n=3). The expression of Tuj-1 was presented as fold activation of light
units normalized to b-actin, whereas the phosphorylations of p44/
42MAPK, Akt, and Stat3 were presented as the fold activations of light
units normalized to p44/42 MAPK, Akt and Stat3, respectively. Cav-1
siRNA versus negative control, * p,0.05, ** p,0.01; Cav-1 siRNA+V1
versus Cav-1 siRNA, # p,0.05, ## p,0.01. Each sample was assayed at
least 3 times.
doi:10.1371/journal.pone.0022901.g016
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RNA transfection was used to knock down the expression of Cav-1
in NPCs. NPCs were transfected with Cav-1 Stealth
TM RNAi. All
data were obtained at day 14. A. Representative immunoblot
detection for phosphorylation of Stat3 in NPCs treated
by Cav-1 specific knockdown with or without V1
treatment (Mean 6 S.D., n=3). VEGF inhibitor V1 (12 mM)
was used to treat NPCs prior to transfection of Cav-1 Stealth
TM
RNAi. Cell lysates were blotted with the p-Stat3 (Ser727)
antibody, in which Stat3 was used as internal reference. NC,
negative control group; siCav-1, Cav-1 RNA silencing group;
siCav-1+V1: Cav-1 RNA silencing+V1 group; B. Statistical
analysis on the phosphorylation of Stat3 (Mean 6 S.D.,
n=3). The phosphorylation of Stat3 was presented as the fold
activation of light units normalized to Stat3. Cav-1 siRNA versus
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